Pharmaceutics 2022, 14(8), 1572; https://doi.org/10.3390/pharmaceutics14081572 - 28 Jul 2022
Best Paper Award
Dear Colleagues,
We are pleased to announce the winners of the Pharmaceutics 2022 Best Paper Award. All papers published from 1 January 2022 to 31 December 2022 in Pharmaceutics were considered for the award. After a thorough evaluation of the originality and significance of the papers, citations, and downloads, three winners were selected.
One Review:
Methods of Liposomes Preparation: Formation and Control Factors of Versatile Nanocarriers for Biomedical and Nanomedicine Application
By Domenico Lombardo and Mikhail A. Kiselev
Pharmaceutics 2022, 14(3), 543; doi:10.3390/pharmaceutics14030543
Two Articles:
mRNA-Loaded Lipid Nanoparticles Targeting Dendritic Cells for Cancer Immunotherapy
By Kosuke Sasaki, Yusuke Sato, Kento Okuda, Kazuki Iwakawa and Hideyoshi Harashima
Pharmaceutics 2022, 14(8), 1572; doi: 10.3390/pharmaceutics14081572
The Potential of Cell-Penetrating Peptides for mRNA Delivery to Cancer Cells
By Yelee Kim, Hyosuk Kim, Eun Hye Kim, Hochung Jang, Yeongji Jang, Sung-Gil Chi, Yoosoo Yang and Sun Hwa Kim
Pharmaceutics 2022, 14(6), 1271; doi:10.3390/pharmaceutics14061271
Each winner will receive CHF 500 and a chance to publish a paper in Pharmaceutics in 2024 after peer review.
Please join us in congratulating the winners of the Pharmaceutics 2022 Best Paper Award. We would also like to take this opportunity to thank all of our authors for your continued support of Pharmaceutics.
Kind regards,
Pharmaceutics Editorial Office
Pharmaceutics Best Paper Award
Eligibility and Requirements
– All papers published in Pharmaceutics will be eligible (Both regular and Special Issue submissions).
Past Winners
Year:
Winner
mRNA-Loaded Lipid Nanoparticles Targeting Dendritic Cells for Cancer Immunotherapy
The Potential of Cell-Penetrating Peptides for mRNA Delivery to Cancer Cells
Pharmaceutics 2022, 14(6), 1271; https://doi.org/10.3390/pharmaceutics14061271 - 15 Jun 2022
Methods of Liposomes Preparation: Formation and Control Factors of Versatile Nanocarriers for Biomedical and Nanomedicine Application
Pharmaceutics 2022, 14(3), 543; https://doi.org/10.3390/pharmaceutics14030543 - 28 Feb 2022
Winner
mRNA, a Revolution in Biomedicine
Pharmaceutics 2021, 13(12), 2090; https://doi.org/10.3390/pharmaceutics13122090 - 5 Dec 2021
Winner
Development of Remdesivir as a Dry Powder for Inhalation by Thin Film Freezing
Pharmaceutics 2020, 12(11), 1002; https://doi.org/10.3390/pharmaceutics12111002 - 22 Oct 2020
Manufacturing Considerations for the Development of Lipid Nanoparticles Using Microfluidics
Pharmaceutics 2020, 12(11), 1095; https://doi.org/10.3390/pharmaceutics12111095 - 15 Nov 2020
Skin Wound Healing Process and New Emerging Technologies for Skin Wound Care and Regeneration
Pharmaceutics 2020, 12(8), 735; https://doi.org/10.3390/pharmaceutics12080735 - 5 Aug 2020
Winner
3D Printed Pellets (Miniprintlets): A Novel, Multi-Drug, Controlled Release Platform Technology
Pharmaceutics 2019, 11(4), 148; https://doi.org/10.3390/pharmaceutics11040148 - 29 Mar 2019
Mathematical Modeling of Release Kinetics from Supramolecular Drug Delivery Systems
Pharmaceutics 2019, 11(3), 140; https://doi.org/10.3390/pharmaceutics11030140 - 21 Mar 2019
Winner
Impact of Particle Size and Polydispersity Index on the Clinical Applications of Lipidic Nanocarrier Systems
Pharmaceutics 2018, 10(2), 57; https://doi.org/10.3390/pharmaceutics10020057 - 18 May 2018
Hyaluronic Acid Decorated Naringenin Nanoparticles: Appraisal of Chemopreventive and Curative Potential for Lung Cancer
Pharmaceutics 2018, 10(1), 33; https://doi.org/10.3390/pharmaceutics10010033 - 12 Mar 2018
